Spirito-maron echocardiographic score: A marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy

Echocardiography

Volumn 31, Issue 6, 2014, Pages 708-715

  Rangel, Inês ^a,b   Gonçalves, Alexandra ^b   De Sousa, Carla ^a,b   Correia, Ana Sofia ^a,b   Pinho, Teresa ^a,b   Madureira, Antõnio José ^a,b   Martins, Elisabete ^a,b   Cardoso, José Silva ^a,b   MacEdo, Filipe ^a,b   MacIel, Maria Júlia ^a,b  

^a Universidade do Porto   (Portugal)

^b University of Porto   (Portugal)

Author keywords

diastolic function; hypertrophic cardiomyopathy; left ventricular hypertrophy

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FUNCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; ECHOGRAPHY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84904039608     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12471     Document Type: Article

References (30)

1. Maron BJ, Gottdiener JS, Epstein SE,: Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428.
2. Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-1785.
3. Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985; 28: 1-83.
4. Olivotto I, Gistri R, Petrone P, et al. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 41: 315-321.
5. Allison JD, Flickinger FW, Wright JC, et al. Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: Comparison with echocardiography. Magn Reson Imaging 1993; 11: 329-334.
6. Bottini PB, Carr AA, Prisant LM, et al. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient[ast]. Am J Hypertens 1995; 8: 221-228.
7. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy. Circulation 2005; 112: 855-861.
8. Sardanelli F, Molinari G, Petillo A, et al. MRI in Hypertrophic Cardiomyopathy: A Morphofunctional Study. J Comput Assist Tomogr 1993; 17: 862-872.
9. Pons-Lladõ MDG, Carreras MDF, Borrás MDX, et al. Comparison of Morphologic Assessment of Hypertrophic Cardiomyopathy by Magnetic Resonance Versus Echocardiographic Imaging. Am J Cardiol 1997; 79: 1651-1656.
10. Charron P, Dubourg O, Desnos M, et al. Diagnostic Value of Electrocardiography and Echocardiography for Familial Hypertrophic Cardiomyopathy in a Genotyped Adult Population. Circulation 1997; 96: 214-219.
11. Spirito P, Maron BJ,: Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15: 1521-1526.
12. Spirito P, Maron BJ, Bonow RO, et al. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 123-129.
13. Posma JL, Blanksma PK, van der Wall EE, et al. Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: Magnetic resonance imaging versus echocardiography. Am Heart J 1996; 132: 1020-1027.
14. Members WC, Gersh BJ, Maron BJ, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: e783-e831.
15. Lang RM, Bierig M, Devereux RB, et al. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
16. Losi M-A, Nistri S, Galderisi M, et al. Echocardiography in patients with hypertrophic cardiomyopathy: Usefulness of old and new techniques in the diagnosis and pathophysiological assessment. Cardiovasc Ultrasound 2010; 8: 7.
17. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. Eur J Echocardiogr 2009; 10: 165-169.
18. Brennan JM, Blair JE, Goonewardena S, et al. Reappraisal of the Use of Inferior Vena Cava for Estimating Right Atrial Pressure. J Am Soc Echocardiogr 2007; 20: 857-861.
19. Myerson SG, Bellenger NG, Pennell DJ,: Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 2002; 39: 750-755.
20. Dong S, MacGregor J, Crawley A, et al. Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study. Circulation 1994; 90: 1200-1209.
21. Hayashida W, Kumada T, Kohno F, et al. Left ventricular regional relaxation and its nonuniformity in hypertrophic nonobstructive cardiomyopathy. Circulation 1991; 84: 1496-1504.
22. Spirito P, Maron B, Chiarella F, et al. Diastolic abnormalities in patients with hypertrophic cardiomyopathy: Relation to magnitude of left ventricular hypertrophy. Circulation 1985; 72: 310-316.
23. Rakowski H, Carasso S,: Quantifying diastolic function in hypertrophic cardiomyopathy. Circulation 2007; 116: 2662-2665.
24. Bonow R, Dilsizian V, Rosing D, et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: Short- and long-term effects. Circulation 1985; 72: 853-864.
25. Ritzema JL, Richards AM, Crozier IG, et al. Serial Doppler echocardiography and tissue Doppler imaging in the detection of elevated directly measured left atrial pressure in ambulant subjects with chronic heart failure. JACC Cardiovasc Imaging 2011; 4: 927-934.
26. Yang H, Woo A, Monakier D, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: A marker for disease severity. J Am Soc Echocardiogr 2005; 18: 1074-1082.
27. Tsang TSM, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284-1292.
28. Caselli S, Pelliccia A, Maron M, et al. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography. Am J Cardiol 2008; 102: 616-620.
29. Chang S-A, Kim H-K, Lee S-C, et al. Assessment of left ventricular mass in hypertrophic cardiomyopathy by real-time three-dimensional echocardiography using single-beat capture image. J Am Soc Echocardiogr 2013; 26: 436-442.
30. Bicudo LS, Tsutsui JM, Shiozaki A, et al. Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: Comparison with two-dimensional echocardiography and magnetic resonance imaging. Echocardiography 2008; 25: 717-726.